Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Common Respiratory Disorders

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

Drugs Used in Upper Respiratory Disorders: Overview

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pluripotency of a founding field: rebranding developmental biology.

Development (Cambridge, England)·2024

Same author

Commentary on classic paper "Gimlich, R.L., Gerhart, J.C., 1984. Early cellular interactions promote embryonic axis formation in Xenopus laevis. Dev Biol 104, 117-130."

Developmental biology·2019

Same author

Dimerization quality control ensures neuronal development and survival.

Science (New York, N.Y.)·2018

Same author

Roles of Wnt pathway genes wls, wnt9a, wnt5b, frzb and gpc4 in regulating convergent-extension during zebrafish palate morphogenesis.

Development (Cambridge, England)·2016

Same author

The POU-er of gene nomenclature.

Development (Cambridge, England)·2014

Same author

miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110.

Nature·2014

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Vaccination for respiratory immunity: latest developments.

Richard Harland¹

¹Novartis Animal Health Canada, Inc., Calgary, Alberta T2V 4M6, Canada. richard.harland@novartis.com

Animal Health Research Reviews

|December 17, 2009

Summary

Recent advances in immunology and molecular biology offer new vaccine strategies for respiratory diseases. These innovations promise safer, more effective, and flexible vaccine options through improved antigen identification and delivery methods.

More Related Videos

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Related Experiment Videos

Last Updated: Jun 17, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Area of Science:

Immunology
Molecular Biology
Vaccinology

Background:

Significant progress in immunology and molecular biology over the past two decades.
Development of novel tools for antigen identification and immune response modulation.

Purpose of the Study:

To review the advancements in vaccine development for respiratory diseases.
To highlight new strategies for antigen discovery and immune response induction.

Main Methods:

Utilizing deletion mutations, subunit antigens, vectors, and DNA immunization.
Employing advanced screening and production techniques for antigens.
Incorporating novel adjuvants for enhanced immune responses.

Main Results:

Increased options for generating optimal immune responses.
Improved methods for antigen screening, discovery, and production.
Development of more effective delivery systems for vaccine antigens.

Conclusions:

New vaccine technologies lead to safer and more efficacious respiratory disease vaccines.
Enhanced flexibility in vaccine use and administration is anticipated.
These advancements represent a significant step forward in combating respiratory illnesses.